S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13

Ceridian HCM Stock Forecast, Price & News

-3.09 (-2.86%)
(As of 12/3/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
1.65 million shs
Average Volume
813,352 shs
Market Capitalization
$15.90 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive CDAY News and Ratings via Email

Sign-up to receive the latest news and ratings for Ceridian HCM and its competitors with MarketBeat's FREE daily newsletter.

Ceridian HCM logo

About Ceridian HCM

Ceridian HCM Holding, Inc. engages in the development of human capital management software. It offers Dayforce, Powerpay, and Bureau products and services. The Dayforce provides human resources (HR), payroll, benefits, workforce management, and talent management functionality. The Powerpay is a cloud HR and payroll solution for the Canadian small business market, through both direct sales and established partner channels. The Bureau solutions offer payroll and payroll-related services using legacy technology. The company was founded on July 3, 2013 and is headquartered in Minneapolis, MN.


Is Ceridian HCM Holding Inc. (CDAY) A Good Long-Term Buy?
November 18, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Prepackaged software
Year Founded

Sales & Book Value

Annual Sales
$842.50 million
Cash Flow
$0.48 per share
Book Value
$14.68 per share


Net Income
$-4 million
Pretax Margin




Free Float
Market Cap
$15.90 billion

Company Calendar

Last Earnings
Fiscal Year End
Next Earnings (Estimated)


Overall MarketRank

1.79 out of 5 stars

Computer And Technology Sector

571st out of 892 stocks

Prepackaged Software Industry

181st out of 267 stocks

Analyst Opinion: 3.3Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 -

Ceridian HCM (NYSE:CDAY) Frequently Asked Questions

Is Ceridian HCM a buy right now?

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ceridian HCM in the last year. There are currently 1 sell rating, 4 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Ceridian HCM stock.
View analyst ratings for Ceridian HCM
or view top-rated stocks.

How has Ceridian HCM's stock price been impacted by Coronavirus (COVID-19)?

Ceridian HCM's stock was trading at $56.63 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CDAY shares have increased by 85.5% and is now trading at $105.07.
View which stocks have been most impacted by COVID-19

When is Ceridian HCM's next earnings date?

Ceridian HCM is scheduled to release its next quarterly earnings announcement on Tuesday, February 8th 2022.
View our earnings forecast for Ceridian HCM

How were Ceridian HCM's earnings last quarter?

Ceridian HCM Holding Inc. (NYSE:CDAY) released its quarterly earnings results on Wednesday, November, 3rd. The company reported $0.05 EPS for the quarter, beating the Zacks' consensus estimate of ($0.09) by $0.14. Ceridian HCM had a negative trailing twelve-month return on equity of 1.86% and a negative net margin of 8.62%.
View Ceridian HCM's earnings history

What guidance has Ceridian HCM issued on next quarter's earnings?

Ceridian HCM updated its FY 2021 earnings guidance on Wednesday, November, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.01 billion-$1.02 billion, compared to the consensus revenue estimate of $1.25 billion.

What price target have analysts set for CDAY?

12 brokers have issued 1 year price targets for Ceridian HCM's shares. Their forecasts range from $95.00 to $150.00. On average, they expect Ceridian HCM's stock price to reach $121.17 in the next twelve months. This suggests a possible upside of 15.3% from the stock's current price.
View analysts' price targets for Ceridian HCM
or view top-rated stocks among Wall Street analysts.

Who are Ceridian HCM's key executives?

Ceridian HCM's management team includes the following people:
  • David D. Ossip, Chairman & Chief Executive Officer
  • Leagh E. Turner, President & Chief Operating Officer
  • Noemie C. Heuland, Chief Financial Officer & Executive Vice President
  • Joe Korngiebel, Chief Product & Technology Officer, Executive VP
  • William Everett McDonald, Secretary, General Counsel & Executive VP

What is David Ossip's approval rating as Ceridian HCM's CEO?

902 employees have rated Ceridian HCM CEO David Ossip on Glassdoor.com. David Ossip has an approval rating of 92% among Ceridian HCM's employees. This puts David Ossip in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Ceridian HCM own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ceridian HCM investors own include Workday (WDAY), Advanced Micro Devices (AMD), Alibaba Group (BABA), NVIDIA (NVDA), Adobe (ADBE), Alteryx (AYX), Costco Wholesale (COST), ServiceNow (NOW), Paycom Software (PAYC) and Tesla (TSLA).

When did Ceridian HCM IPO?

(CDAY) raised $420 million in an initial public offering on Thursday, April 26th 2018. The company issued 21,000,000 shares at a price of $19.00-$21.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse and Deutsche Bank Securities served as the underwriters for the IPO and Barclays, Citigroup, Jefferies, CIBC Capital Markets, Wells Fargo Securities, Baird, Canaccord Genuity, Piper Jaffray, William Blair and MUFG were co-managers.

What is Ceridian HCM's stock symbol?

Ceridian HCM trades on the New York Stock Exchange (NYSE) under the ticker symbol "CDAY."

Who are Ceridian HCM's major shareholders?

Ceridian HCM's stock is owned by many different institutional and retail investors. Top institutional investors include Capital Research Global Investors (12.13%), Cannae Holdings Inc. (7.27%), BlackRock Inc. (5.91%), Capital World Investors (4.95%), Janus Henderson Group PLC (4.39%) and Artisan Partners Limited Partnership (2.20%). Company insiders that own Ceridian HCM stock include Arthur Gitajn, Cannae Holdings, Inc, Christopher R Armstrong, David D Ossip, Gerald C Throop, Jeffrey Scott Jacobs, Leagh Erin Turner, Lisa M Sterling, Scott A Kitching, Thomas H Lee Advisors, Llc, Thomas M Hagerty and William Everett Mcdonald.
View institutional ownership trends for Ceridian HCM

Which major investors are selling Ceridian HCM stock?

CDAY stock was sold by a variety of institutional investors in the last quarter, including Capital World Investors, BlackRock Inc., Goldman Sachs Group Inc., Cannae Holdings Inc., Assenagon Asset Management S.A., Principal Financial Group Inc., Bank of New York Mellon Corp, and Morgan Stanley. Company insiders that have sold Ceridian HCM company stock in the last year include Christopher R Armstrong, David D Ossip, Gerald C Throop, Jeffrey Scott Jacobs, Leagh Erin Turner, Thomas M Hagerty, and William Everett Mcdonald.
View insider buying and selling activity for Ceridian HCM
or view top insider-selling stocks.

Which major investors are buying Ceridian HCM stock?

CDAY stock was acquired by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, Invesco Ltd., Geode Capital Management LLC, Artisan Partners Limited Partnership, Capital Research Global Investors, Bamco Inc. NY, Deutsche Bank AG, and Chevy Chase Trust Holdings Inc..
View insider buying and selling activity for Ceridian HCM
or or view top insider-buying stocks.

How do I buy shares of Ceridian HCM?

Shares of CDAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ceridian HCM's stock price today?

One share of CDAY stock can currently be purchased for approximately $105.07.

How much money does Ceridian HCM make?

Ceridian HCM has a market capitalization of $15.90 billion and generates $842.50 million in revenue each year. The company earns $-4 million in net income (profit) each year or ($0.56) on an earnings per share basis.

How many employees does Ceridian HCM have?

Ceridian HCM employs 5,974 workers across the globe.

What is Ceridian HCM's official website?

The official website for Ceridian HCM is www.ceridian.com.

Where are Ceridian HCM's headquarters?

Ceridian HCM is headquartered at 3311 EAST OLD SHAKOPEE ROAD, MINNEAPOLIS MN, 55425.

How can I contact Ceridian HCM?

Ceridian HCM's mailing address is 3311 EAST OLD SHAKOPEE ROAD, MINNEAPOLIS MN, 55425. The company can be reached via phone at (952) 853-8100 or via email at [email protected].

This page was last updated on 12/5/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.